Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Sediment Analysis × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Cyclophosphamide 2681 Cisplatin 2665 Carboplatin 2462 Radiotherapy 2370 Paclitaxel 2264 Gemcitabine 2128 pembrolizumab 1993 Docetaxel 1883 Bevacizumab 1821 Fluorouracil 1548 Capecitabine 1532 Oxaliplatin 1440 Dexamethasone 1330 Nivolumab 1300 Doxorubicin 1260 Rituximab 1249 Magnetic Resonance Spectroscopy 1150 Etoposide 1126 Irinotecan 1038 Leucovorin 1020 Drug Therapy 999 Cytarabine 964 Pemetrexed 891 fludarabine 889 Specimen Handling 822 Vincristine 793 Lenalidomide 791 Cetuximab 785 Prednisone 785 Trastuzumab 785

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00126958 2009-02-19

Cost-Effectiveness in Bladder Cancer

Erasmus Medical Center

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡